Skip to main content
Signal8

Martin Celine Christine

SEC insider (Form 3/4/5 filer). CIK 0002092680. Director at FULLER H B CO (FUL) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in ST. PAUL, MN.

Companies Martin Celine Christine has filed insider reports for

  • FULLER H B CO (FUL): Director
  • CONMED Corp (CNMD): Director
Martin Celine Christine profile photo

Martin Celine Christine

CIK: 0002092680

Transaction Breakdown

Open Market Buys (P)1 (20.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

FULLER H B CO logo
FUL

FULLER H B CO

Director
CONMED Corp logo
CNMD

CONMED Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • FULLER H B CO logo
    FUL

    FULLER H B CO

    Sep 30, 2026
    Purchase
    Direct
    465 shares at avg. $49.50$23K
  • FULLER H B CO logo
    FUL

    FULLER H B CO

    Jul 15, 2026
    Award

    Stock Units

    Direct
    2.9K shares at avg. $57.00-
  • CONMED Corp logo
    CNMD

    CONMED Corp

    Jul 1, 2026
    Award

    RSUs (Restricted Stock Units)

    Direct
    5.6K shares-
  • FULLER H B CO logo
    FUL

    FULLER H B CO

    Jan 26, 2026
    Award

    Restricted Stock Units

    Direct
    1.3K shares-
  • FULLER H B CO logo
    FUL

    FULLER H B CO

    Jan 26, 2026
    Award

    Restricted Stock Units

    Direct
    1.3K shares-

1-5 of 5